READ-ONLY DIGITIZATION RESULT
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma.
Clin Cancer Res · 2026-Apr-01 · PMID 41537702
Panel D提取完成待 EXE 对齐验证
OS
Figure 1. PFS and OS for encorafenib plus binimetinib or encorafenib vs. vemurafenib by ( A and B ) TMB and ( C and D ) cytolytic score. E, Volcano plots of univariable gene expression associations with OS in each arm based on z -scored gene expression values. F, Gene-set enrichment analysis of gene expression associations against hallmark gene signatures; signatures with greatest average NES across arms shown. Bini, binimetinib; BM, biomarker; CYT, cytotoxic score; Enco, encorafenib; NES, normalized enrichment scores; Vemu, vemurafenib.
算法:legacy-0.5.0引擎:enhanced-linux
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | complete | 待验证 | 6 | 2026-07-23T16:56:28+00:00 |